Both normal and pathological actions of VEGF-A, including tumor proliferation and vascular endothelial cell permeability, are typically thought to occur via VEGFR2, despite the receptor’s lower affinity for VEGF-A relative to VEGFR1 [32,34]. This evidence concerns the gene VEGFA and neoplasm.